Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Autologous Adipose Derived Stem Cell
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase I
Recipient : Arkansas Heart Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Preliminary Efficacy of Adipose Derived Stem Cells and Low Frequency Ultrasound in PAD
Details : Undisclosed
Product Name : Undisclosed
Product Type : Cell and Gene therapy
Upfront Cash : Inapplicable
April 29, 2016
Lead Product(s) : Autologous Adipose Derived Stem Cell
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase I
Recipient : Arkansas Heart Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable